{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:43:55Z","timestamp":1783435435323,"version":"3.54.6"},"reference-count":28,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institutional Fund Projects","award":["IFPIP: 561-247-1443"],"award-info":[{"award-number":["IFPIP: 561-247-1443"]}]},{"name":"Ministry of Education and King Abdulaziz University, DSR, Jeddah, Saudi Arabia","award":["IFPIP: 561-247-1443"],"award-info":[{"award-number":["IFPIP: 561-247-1443"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Methotrexate (MTX) is currently the most widely used treatment for Rheumatoid Arthritis (RA) due to its demonstrated efficacy and well-known safety profile. However, the effectiveness and toxicity of MTX can vary among patients, partly due to genetic factors. Therefore, this study aimed to investigate the associations between the polymorphisms in the ABC subfamily G member 2 (ABCG2) gene and MTX effectiveness\/toxicity in Saudi Arabia RA patients. Methods: The study is a retrospective, multicenter, case\u2013control study that uses Sanger sequencing techniques for genotyping. Results: More than half of the patients (55.56%) were poor responders, with a slightly higher mean age. However, there was no significant difference between the two groups, not only in terms of age but also in other demographics and clinical factors. Regarding the rs2231137 polymorphism, the CC, CT, and TT genotype frequency were 91%, 7%, and 2%, respectively. The mutated variant (TT) was only observed in the positive rheumatoid factor group. Notably, none of these genotypes displayed any significant correlation with demographic characteristics, clinical features, or MTX efficacy\/toxicity. Conclusions: This study is the first pharmacogenetic study of rs2231137 polymorphism in RA patients utilizing linear regression, revealing that rs2231137 polymorphism is not a predictor of either MTX efficacy or toxicity in RA patients. Therefore, more research is needed.<\/jats:p>","DOI":"10.3390\/ph18091365","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:34:03Z","timestamp":1757680443000},"page":"1365","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of ABCG2 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-566X","authenticated-orcid":false,"given":"Zeina W.","family":"Sharawi","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina A.","family":"Alqurashi","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam M.","family":"Alharthi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-781X","authenticated-orcid":false,"given":"Ibtisam M.","family":"Jali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha H.","family":"Jamal","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Bawazir","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0170-3747","authenticated-orcid":false,"given":"Mohammad","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Rheumatology Unite, Department of Medicine, Faculty of Medicine, University of Jeddah, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami M.","family":"Bahlas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Daghasi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Internal Medicine Department, Al Hada Armed Forces Hospital, Taif 26792, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-2528","authenticated-orcid":false,"given":"Talal S.","family":"Alharthi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, King Abdulaziz Specialist Hospital, Ministry of Health, Taif 26792, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal Sameer","family":"Al Shaer","sequence":"additional","affiliation":[{"name":"Department of Genetic Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-4068","authenticated-orcid":false,"given":"Rania","family":"Magadmi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid Arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.apmr.2020.04.001","article-title":"A Systematic Review of the Incidence, Prevalence, Costs, and Activity and Work Limitations of Amputation, Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis, Spinal Cord Injury, Stroke, and Traumatic Brain Injury in the United States: A 2019 Update","volume":"102","author":"Lo","year":"2021","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.berh.2004.08.009","article-title":"Therapeutic Strategies in Early Rheumatoid Arthritis","volume":"19","author":"Smolen","year":"2005","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-014-2818-5","article-title":"Rheumatoid Arthritis in the Middle East and Africa: Are We Any Closer to Optimising Its Management?","volume":"34","author":"Ragab","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/rheumatology\/41.12.1367","article-title":"The Rheumatoid Arthritis Patient in the Clinic: Comparing More than 1300 Consecutive DMARD Courses","volume":"41","author":"Aletaha","year":"2002","journal-title":"Rheumatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/rheumatology\/keg036","article-title":"The Effect of Treatment on Radiological Progression in Rheumatoid Arthritis: A Systematic Review of Randomized Placebo-Controlled Trials","volume":"42","author":"Jones","year":"2003","journal-title":"Rheumatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/rheumatology\/41.12.1346","article-title":"Evidence from Clinical Trials and Long-Term Observational Studies That Disease-Modifying Anti-Rheumatic Drugs Slow Radiographic Progression in Rheumatoid Arthritis: Updating a 1983 Review","volume":"41","author":"Pincus","year":"2002","journal-title":"Rheumatology"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Dargham, S.R., Zahirovic, S., Hammoudeh, M., Al Emadi, S., Masri, B.K., Halabi, H., Badsha, H., Uthman, I., Mahfoud, Z.R., and Ashour, H. (2018). Epidemiology and Treatment Patterns of Rheumatoid Arthritis in a Large Cohort of Arab Patients. PLoS ONE, 13, Correction in PLoS ONE 2018, 13, e0214258.","DOI":"10.1371\/journal.pone.0208240"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.31138\/mjr.33.2.224","article-title":"Therapeutic Maintenance Level of Methotrexate in Rheumatoid Arthritis: A RBSMR Study","volume":"33","author":"Oulkadi","year":"2022","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_10","first-page":"e27047","article-title":"Safety Profile of Methotrexate Therapy in Patients With Rheumatoid Arthritis","volume":"14","author":"Mustafa","year":"2022","journal-title":"Cureus"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/FPC.0b013e328343dd93","article-title":"PharmGKB Summary: Methotrexate Pathway","volume":"21","author":"Mikkelsen","year":"2011","journal-title":"Pharmacogenet Genom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2217\/14622416.9.4.439","article-title":"An Update on Methotrexate Pharmacogenetics in Rheumatoid Arthritis","volume":"9","author":"Ranganathan","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.addr.2012.09.027","article-title":"Mammalian Drug Efflux Transporters of the ATP Binding Cassette (ABC) Family: An Overview","volume":"64","author":"Schinkel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00280-004-0931-x","article-title":"Single Nucleotide Polymorphisms Modify the Transporter Activity of ABCG2","volume":"56","author":"Morisaki","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ijc.11669","article-title":"Single Nucleotide Polymorphisms Result in Impaired Membrane Localization and Reduced Atpase Activity in Multidrug Transporter ABCG2","volume":"109","author":"Mizuarai","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_16","first-page":"611","article-title":"C421A Polymorphism in the Human Breast Cancer Resistance Protein Gene Is Associated with Low Expression of Q141K Protein and Low-Level Drug Resistance","volume":"1","author":"Imai","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/jps.24366","article-title":"Quantitative Analysis of the ABCG2 c.421C>A Polymorphism Effect on in Vivo Transport Activity of Breast Cancer Resistance Protein (BCRP) Using an Intestinal Absorption Model","volume":"104","author":"Tanaka","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"ref_18","unstructured":"GBD 2021 Rheumatoid Arthritis Collaborators (2023). Global, Regional, and National Burden of Rheumatoid Arthritis, 1990\u20132020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol., 5, e594\u2013e610."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Raine, C., and Giles, I. (2022). What Is the Impact of Sex Hormones on the Pathogenesis of Rheumatoid Arthritis?. Front. Med., 9.","DOI":"10.3389\/fmed.2022.909879"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jsps.2012.05.004","article-title":"Adverse Drug Reactions Caused by Methotrexate in Saudi Population","volume":"20","year":"2012","journal-title":"Saudi Pharm. J."},{"key":"ref_21","first-page":"327","article-title":"Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study","volume":"15","author":"Cen","year":"2022","journal-title":"Pharmgenom. Pers. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Brynedal, B., Yoosuf, N., Ulfarsdottir, T.B., Ziemek, D., Maciejewski, M., Folkersen, L., Westerlind, H., M\u00fcller, M., Sahlstr\u00f6m, P., and Jelinsky, S.A. (2023). Molecular Signature of Methotrexate Response among Rheumatoid Arthritis Patients. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1146353"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-022-02851-5","article-title":"Clinical Predictors of Response to Methotrexate in Patients with Rheumatoid Arthritis: A Machine Learning Approach Using Clinical Trial Data","volume":"24","author":"Duong","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/tpj.2016.36","article-title":"Clinical-Pharmacogenetic Predictive Models for MTX Discontinuation Due to Adverse Events in Rheumatoid Arthritis","volume":"17","author":"Jenko","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"ref_25","first-page":"S93","article-title":"The Disease Activity Score and the EULAR Response Criteria","volume":"23","author":"Fransen","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Magadmi, R., Alyoubi, R., Moshrif, T., Bakhshwin, D., Suliman, B.A., Kamel, F., Jamal, M., Burzangi, A.S., and Basit, S. (2023). Polymorphisms in the Drug Transporter Gene ABCB1 Are Associated with Drug Response in Saudi Epileptic Pediatric Patients. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092505"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Magadmi, R., Alharthi, A.M., Alqurashi, L.A., Jali, I.M., Sharawi, Z.W., Jamal, M.H., Bawazir, Y., Mustafa, M., Bahlas, S.M., and Jamal, B.T. (2025). Association of SLCO1B3 and SLCO1B1 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients. Pharmaceuticals, 18.","DOI":"10.3390\/ph18071069"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: A Web Tool for the Analysis of Association Studies","volume":"22","author":"Valls","year":"2006","journal-title":"Bioinformatics"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/9\/1365\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:44:40Z","timestamp":1760035480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/9\/1365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ph18091365"],"URL":"https:\/\/doi.org\/10.3390\/ph18091365","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}